LBT-3627
LBT-3627-101
Phase 1 small_molecule active
Quick answer
LBT-3627 for Parkinson Disease is a Phase 1 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Parkinson Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active